Description
The Centers for Disease Control and Prevention (CDC) National Center for Immunizations and Respiratory Diseases (NCIRD) intends to award a Firm Fixed Price Contract to Southern Research Institute to assess the safety of a Live Attenuated Rotavirus Vaccine (LARV) Microneedle (MN) patch for vaccination against rotavirus when given intradermally for four (4) administrations in rats. The project's objectives are to evaluate the safety of the MN patch in accordance with regulatory requirements.
• The contract will be awarded under the authority of FAR 13.106-1(b)(1)(i) and 10 U.S.C. 2304(c) (1).
• The Period of Performance is from May 15, 2026, to May 14, 2028.
• Interested sources are required to submit a capability statement that includes management and technical data and cost information.
• Capability Statements shall not exceed 2 pages using a font size no smaller than 10-point.
Attached files
The solicitation documents live at the source — open the bid source above to download them.